Industry News
Medical Device Industry News
Christopher Whitmore Appointed CFO at Ray Therapeutics
Christopher Whitmore is a highly accomplished executive who brings over 20 years of strategic finance, accounting, and operational expertise. His deep experience spans from early-stage biotech to publicly-traded companies, with a focus on both private
Andy Fuller Appointed VP of Market Access at AESAR
With over 27 years of experience in the pharmaceutical industry, Andy Fuller brings extensive expertise in developing and executing go-to-market and payer engagement strategies across highly competitive markets.
Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy
"Receiving both Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 is a significant milestone for Somite Therapeutics and, more importantly, for patients suffering from Duchenne muscular dystrophy," said Dr. Micha Breakstone, Founder and CEO
Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
MindLight is the first circular RNA biomarker-based assay designed to predict whether a patient with depression, also known as major depressive disorder, will respond to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.
EDETEK Announces New Insights on Conducting End-to-End Clinical Trial Solutions
This session, entitled, "Transforming Clinical Trials: From Reactive to Predictive," takes place during the DPHARM Innovative Collaborations Track C, on Tuesday, September 17, 2024, at 4:10pm EDT reports Edetek.
Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings
Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized
Sheba Medical Center to Utilize Sequentify’s InfiniSeq Panel in Study to Detect Clonal Hematopoiesis in Cancer Patients
Sequentify's InfiniSeq technology reduces sample preparation time to just 3.15 hours, from DNA extraction to sequencing, using a single-tube reaction. It supports full automation and significantly reduces costs. The patent-pending InfiniSeq technology is compatible with
Optimizing Emergency Medical Services With Advanced Patient Data Management
How Better Data Management Improves Emergency Medical Services In emergency medical services (EMS), each minute is valuable, and service response must occur fast enough to save lives. They make critical decisions involving patients’ lives with
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
“The Decipher Prostate test’s ability to help guide treatment for patients with localized prostate cancer is already proven in dozens of peer-reviewed publications and is the only molecular test to achieve ‘Level 1B’ evidence status
Urban Poling Supports VeDA’s International Balance Awareness Week
Urban Poling Inc. is a Canadian company and a global leader in the promotion of fitness and rehabilitation through pole walking.
LifestyledAI, Dongguk University Startup Technology Institute & UMUST R&D Partner | To Advance Global AI Deep Tech and Healthcare Businesses
LifestyledAI is an AI deep-tech startup that seeks to revolutionize customer lifestyles through its proprietary AI-based technologies, including AI Ultra-Real Fitting for highly realistic virtual fashion and beauty try-ons, and a precise, easy-to-use AI body
GN BODYDOCTOR | A Kegel Muscle Exerciser & Effective Solution for Pelvic Muscle Health Concerns
GN BODYDOCTOR is a medical device proven to effectively address a wide range of pelvic health issues, including prostate health, urinary incontinence, fecal incontinence, sexual dysfunction, constipation, hemorrhoids, sciatica, uterine prolapse, and sagging hip muscles.
Matia Mobility Secures HCPCS Code for Tek RMD: A Groundbreaking Solution Now Covered by Medicare, Commercial Insurance, and the VA
Matia Mobility notes the Tek RMD, now covered by Medicare, commercial insurance, and the U.S. Veterans Administration, is revolutionizing mobility by enabling users to stand and move at eye level, empowering them to participate fully
Nordic Biotech Company Pila Pharma Raises Capital for New International Obesity Study
According to According to Pila Pharma, the capital raised will support the study with the objective to assess the molecule’s safety in increased dosages, as well as to expand on the number of study participants
Transform Your Smile with Gummy Smile Makeover using a Cosmetic Dentist in London
A radiant smile is often regarded as a universal symbol of happiness and confidence. Yet, for some individuals, the aesthetic appeal of their smile may be hindered by what is commonly referred to as a
Medtronic Hires Dr James Porter, One of the Nation’s Top Surgeons as CMO
A practicing urologic surgeon who has performed more than 5,000 robotic-assisted procedures, Dr James Porter is a recognized leader among the global surgical community and one of the top five robotic surgery practitioners in the
In Vitro Diagnostics Quality Controls Global Markets: Revenue Data for 2021-2023, Estimated Figures for 2024, and Projected CAGRs Through 2029
The "In Vitro Diagnostics Quality Controls: Global Market" report has been added to ResearchAndMarkets.com's offering.
U.S. Nursing Care Focused Insights Report 2024-2029
The U.S. nursing care market was valued at USD 475.15 billion in 2023 and is expected to reach a value of $692.19 billion by 2029, growing at a CAGR of 6.47% from 2023 to 2029.
Synaptogenix Announces $5.0 Million Financing
"We are pleased to benefit from the support of our committed long-term investors in this financing," said Dr. Alan Tuchman, Chief Executive Officer of Synaptogenix. "This capital enhances our ability to be both strategic and
Getinge Completes the Acquisition of Paragonix Technologies
Getinge paid approximately USD 253 million in cash upon completion of the acquisition, on a cash and debt free basis. The earn-out payments are expected to be paid between 2024 and 2026 if agreed upon